Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Plos Biology|June 30, 2010
Innate-like control of human iNKT cell autoreactivity via the hypervariable CDR3beta loopGediminas Matulis, Joseph P Sanderson, Nikolai M Lissin, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Crystallization and preliminary X-ray structural studies of a high-affinity CD8alphaalpha co-receptor to pMHCDavid K Cole, Pierre J Rizkallah, Malkit Sami, et al.
The Journal of Experimental Medicine|March 8, 2006
Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptorsStephan D Gadola, Michael Koch, Jon Marles-Wright, et al.
Cancer Immunology, Immunotherapy : CII|December 25, 2012
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumorsEmmet McCormack, Katherine J Adams, Namir J Hassan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
CD1b-restricted GEM T cell responses are modulated by Mycobacterium tuberculosis mycolic acid meromycolate chainsAndrew Chancellor, Anna S Tocheva, Chris Cave-Ayland, et al.
The Journal of Experimental Medicine|April 20, 2005
Structural and kinetic basis for heightened immunogenicity of T cell vaccinesJi-Li Chen, Guillaume Stewart-Jones, Giovanna Bossi, et al.
Protein & Cell|January 8, 2011
High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activationRuth K Moysey, Yi Li, Samantha J Paston, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2016
Cholesteryl esters stabilize human CD1c conformations for recognition by self-reactive T cellsSalah Mansour, Anna S Tocheva, Chris Cave-Ayland, et al.
Nature Medicine|May 8, 2012
Monoclonal TCR-redirected tumor cell killingNathaniel Liddy, Giovanna Bossi, Katherine J Adams, et al.
Pageof 1